BRUKER CORPORATION Finite-Lived Intangible Assets, Net
BRUKER CORPORATION (BRKR) had Finite-Lived Intangible Assets, Net of $867.80 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsNet · last filed 2026-08-05
- 2026-06-30: Finite-Lived Intangible Assets, Net $867.80M.
- 2026-03-31: Finite-Lived Intangible Assets, Net $902.40M.
- 2025-12-31: Finite-Lived Intangible Assets, Net $899.60M.
- 2025-09-30: Finite-Lived Intangible Assets, Net $918.90M.
| Period end | Finite-Lived Intangible Assets, Net |
|---|---|
| 2026-06-30 | $867.80M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $902.40M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $899.60M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $918.90M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $969.60M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $901.70M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $912.50M 10-K · filed 2026-02-27 |
| 2024-09-30 | $1.03B 10-Q · filed 2024-11-07 |
| 2024-06-30 | $1.02B 10-Q · filed 2024-08-09 |
| 2024-03-31 | $449.20M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $330.50M 10-K · filed 2025-03-03 |
| 2023-09-30 | $291.90M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $300.40M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $298.50M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $270.90M 10-K · filed 2024-02-29 |
| 2022-09-30 | $214.00M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $233.50M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $227.50M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $211.80M 10-K · filed 2023-03-01 |
| 2021-09-30 | $217.70M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $205.90M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $213.40M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $229.10M 10-K · filed 2022-02-28 |
| 2020-09-30 | $231.00M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $218.20M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $221.20M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $233.20M 10-K · filed 2021-03-01 |
| 2019-09-30 | $234.30M 10-Q · filed 2019-11-04 |
| 2019-06-30 | $246.30M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $219.30M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $218.70M 10-K · filed 2020-03-27 |
| 2018-09-30 | $98.10M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $87.40M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $76.10M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $81.80M 10-K · filed 2019-03-01 |
| 2017-09-30 | $88.40M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $91.60M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $85.30M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $69.10M 10-K · filed 2018-03-16 |
| 2016-09-30 | $60.70M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $65.20M 10-Q · filed 2016-08-05 |
| 2016-03-31 | $69.70M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $74.10M 10-K · filed 2017-03-01 |
| 2015-09-30 | $65.60M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $73.00M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $77.40M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $77.50M 10-K · filed 2016-02-29 |
| 2014-09-30 | $82.90M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $89.90M 10-Q · filed 2014-08-08 |
| 2014-03-31 | $94.80M 10-Q · filed 2014-05-09 |
| 2013-12-31 | $99.90M 10-K · filed 2015-02-27 |
| 2013-09-30 | $102.70M 10-Q · filed 2013-11-08 |
| 2013-06-30 | $100.40M 10-Q · filed 2013-08-08 |
| 2013-03-31 | $105.40M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $111.30M 10-K · filed 2014-02-27 |
| 2012-09-30 | $128.10M 10-Q · filed 2012-11-08 |
| 2012-06-30 | $132.70M 10-Q · filed 2012-08-09 |
| 2012-03-31 | $141.30M 10-Q · filed 2012-05-09 |
| 2011-12-31 | $128.40M 10-K · filed 2013-02-28 |
| 2011-09-30 | $125.20M 10-Q · filed 2011-11-09 |
| 2011-06-30 | $116.30M 10-Q · filed 2011-08-09 |
| 2010-12-31 | $114.80M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |